Top 50 Medical Device VC Funds & Investors in Canada (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Archangel Network of Funds
VC Fund
|
15 | Canada, United States | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Software, Medical Device | $10k–$19M |
|
Anges Quebec
VC Fund
|
14 | Canada, United States, Spain | Seed, Venture - Series Unknown, Angel | Software, Health Care, Artificial Intelligence | $376k–$8.5M |
|
Innovacorp
VC Fund
|
13 | Canada, United States, Australia | Seed, Grant, Pre-Seed | Software, Health Care, Information Technology | $19k–$3.1M |
|
Innovate Calgary
VC Fund
|
13 | Canada, United States | Seed, Pre-Seed | Health Care, Medical, Medical Device | $48k–$2.1M |
|
Threshold Impact
VC Fund
|
12 | Canada, United States | Seed, Pre-Seed, Series A | Health Care, Medical Device, Medical | $281k–$15M |
|
iGan Partners
VC Fund
|
11 | Canada, United States, Israel | Seed, Series A, Venture - Series Unknown | Health Care, Software, Medical | $500k–$17M |
|
Startup TNT
VC Fund
|
10 | Canada, United States | Pre-Seed, Seed, Series B | Software, Health Care, Medical Device | $25k–$2.1M |
|
Business Development Bank of Canada
VC Fund
|
9 | Canada, United States, Nigeria | Venture - Series Unknown, Seed, Debt Financing | Software, Information Technology, Manufacturing | $100k–$78M |
|
NorthSpring Capital Partners
VC Fund
|
9 | Canada, United States | Seed, Series A, Pre-Seed | Health Care, Medical Device, Software | $675k–$11M |
|
WUTIF
VC Fund
|
8 | Canada | Seed, Pre-Seed, Venture - Series Unknown | Software, Health Care, Biotechnology | $100k–$5.5M |
|
MEDTEQ+
VC Fund
|
8 | Canada, United States | Seed, Series A, Venture - Series Unknown | Health Care, Medical Device, Biotechnology | $1.5M–$20M |
|
Toronto Innovation Acceleration Partners
VC Fund
|
8 | Canada, United States | Seed, Pre-Seed, Grant | Health Care, Biotechnology, Software | $13k–$8M |
|
MaRS Investment Accelerator Fund
VC Fund
|
8 | Canada, United States | Seed, Pre-Seed, Series A | Software, Analytics, Artificial Intelligence | $375k–$14M |
|
E-Fund
VC Fund
|
8 | Canada, China, United States | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Medical, Medical Device | $279k–$43M |
|
Angel One Network
VC Fund
|
7 | Canada, United States, Malaysia | Angel, Seed, Series A | Software, SaaS, Internet | $68k–$7M |
|
Ontario Centre of Innovation
VC Fund
|
7 | Canada, United States | Seed, Pre-Seed, Grant | Health Care, Software, Medical | $7.3k–$3.2M |
|
Zoic Capital
VC Fund
|
6 | United States, Canada | Seed, Series A, Series B | Health Care, Biotechnology, Medical | $3M–$7.2M |
|
Ontario Brain Institute
VC Fund
|
6 | Canada, United States, France | Grant, Seed, Venture - Series Unknown | Health Care, Medical Device, Medical | $38k–$14M |
|
BDC Venture Capital
VC Fund
|
6 | Canada, United States, United Kingdom | Seed, Series A, Venture - Series Unknown | Software, Information Technology, Artificial Intelligence | $387k–$40M |
|
Thin Air Labs
VC Fund
|
5 | Canada | Seed, Venture - Series Unknown | Software, Health Care, Medical | $1M–$5.2M |
|
FACIT
VC Fund
|
5 | Canada, United States | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Medical Device | $1.5M–$35M |
|
Ontario Centres of Excellence
VC Fund
|
5 | Canada, United States | Seed, Grant, Pre-Seed | Software, Information Technology, Health Care | |
|
Boutique Venture Partners
VC Fund
|
5 | United States, Canada, France | Seed, Series A, Pre-Seed | Health Care, Medical, Biotechnology | $1.8M–$31M |
|
Golden Triangle Angel Network
VC Fund
|
5 | Canada, United States, China | Angel, Seed, Grant | Software, Health Care, Information Technology | $400k–$2.4M |
|
Grand Challenges Canada
VC Fund
|
5 | Canada, United States, India | Grant, Debt Financing, Seed | Health Care, Medical Device, Biotechnology | $100k–$11M |
|
Atlantic Canada Opportunities Agency
VC Fund
|
5 | Canada, United States, France | Grant, Debt Financing, Seed | Manufacturing, Software, Health Care | $25k–$2M |
|
Sunhope Capital
VC Fund
|
4 | Canada, United States, Austria | Seed, Venture - Series Unknown, Pre-Seed | Health Care, Medical Device, Health Diagnostics | $100k–$2.5M |
|
The 51 Ventures
VC Fund
|
4 | Canada, United States, United Kingdom | Seed, Grant, Pre-Seed | Health Care, Software, Information Technology | $273k–$4.2M |
|
Genome British Columbia
VC Fund
|
4 | Canada | Seed, Venture - Series Unknown, Grant | Health Care, Biotechnology, Medical | $370k–$4.7M |
|
Garage Capital
VC Fund
|
4 | Canada, United States, Israel | Seed, Series A, Pre-Seed | Software, Information Technology, Artificial Intelligence | $765k–$50M |
|
Graphene Ventures
VC Fund
|
4 | United States, Brazil, Saudi Arabia | Series A, Seed, Venture - Series Unknown | Software, Health Care, Information Technology | $1.4M–$170M |
|
Bluesky Equities
VC Fund
|
4 | Canada, United States | Seed, Series A, Series B | Software, Information Technology, Analytics | $500k–$43M |
|
Accelerate Fund
VC Fund
|
4 | Canada, United States | Seed, Series A, Venture - Series Unknown | Software, Health Care, Information Technology | $360k–$13M |
|
Whitecap Venture Partners
VC Fund
|
4 | Canada, United States, Spain | Series A, Seed, Series B | Software, Health Care, Enterprise Software | $1.9M–$33M |
|
Boreal Ventures
VC Fund
|
4 | Canada, Spain | Seed, Pre-Seed, Series A | Software, Health Care, Artificial Intelligence | $481k–$12M |
|
Leva Capital
VC Fund
|
4 | Canada, United States | Seed, Pre-Seed, Series A | Health Care, Medical, Biotechnology | $893k–$15M |
|
Desjardins Capital
VC Fund
|
3 | Canada | Seed, Series A, Private Equity | Manufacturing, Software, Information Technology | $1M–$30M |
|
Avego Management
VC Fund
|
3 | United States, Canada, United Kingdom | Series A, Series C | Biotechnology, Pharmaceutical, Medical | $40M–$197M |
|
Cur8 Capital
VC Fund
|
3 | United Kingdom, United States, Canada | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, FinTech | $500k–$19M |
|
Kyto Technology and Life Science Inc
VC Fund
|
3 | United States, Canada | Seed, Series A | Health Care, Medical, Biotechnology | $1.4M–$15M |
|
Fonds de solidarité FTQ
VC Fund
|
3 | Canada, United States, Israel | Series A, Series B | Manufacturing, Biotechnology, Software | $6M–$75M |
|
Nimbus Synergies Inc.
VC Fund
|
3 | Canada, United States | Seed, Series A, Non-Equity Assistance | Health Care, Software, Medical Device | $750k–$7.3M |
|
Amplify Capital
VC Fund
|
3 | Canada, United States, India | Seed, Series A, Pre-Seed | Health Care, Artificial Intelligence, Education | $1.2M–$28M |
|
Zcube
VC Fund
|
3 | Italy, Canada, Lithuania | Seed, Pre-Seed, Series B | Health Care, Medical Device, Medical | $56k–$1.5M |
|
Broadview Ventures
VC Fund
|
3 | United States, Switzerland, Canada | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $1M–$45M |
|
Pool Global Partners
VC Fund
|
3 | Canada, United States, Denmark | Seed, Pre-Seed, Series A | Health Care, Software, Artificial Intelligence | $900k–$5M |
|
Desjardins-Innovatech
VC Fund
|
3 | Canada, Spain | Seed, Venture - Series Unknown, Series B | Health Care, Software, Manufacturing | $365k–$29M |
|
Real Ventures
VC Fund
|
3 | Canada, United States, Australia | Seed, Series A, Series B | Software, Artificial Intelligence, Machine Learning | $592k–$47M |
|
Genesys Capital
VC Fund
|
3 | Canada, United States | Series A, Series B | Biotechnology, Health Care, Medical | $1.8M–$105M |
|
Equation Angels
VC Fund
|
3 | Canada | Seed, Pre-Seed | Health Care, Medical Device, Medical | $675k–$1.5M |
| Access all 595 VC funds in Canada Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Archangel is the overarching early stage investment fund based in Waterloo Region, the North Silicon Valley of North America.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Canada, United States
Investor stats
- Total investments: 69
- Round size: Seed $10k–$3.8M; Pre-Seed $700k–$1.6M; Venture - Series Unknown $1.6M–$19M
- Lead/follow: 6% lead, 94% follow
- Last fund: May invest from a new fund soon — raised $10M in 2021
Portfolio highlights
- myStoria — Backed by fertility doctors. Built by patients, for patients. Track symptoms, manage diagnoses, get advice, and start moving forward.
- Streamforge — Streamforge helps companies find the most relevant creators for their games and products using the most sophisticated platform and technology on the market.
- TimeSmart.AI — A healthcare-focused solution for contract management, clinician timesheet review and approvals, payment tracking & contract compliance enforcement
Value-added investors for innovative entrepreneurs.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown, Angel
- Geography: Canada, United States, Spain
Investor stats
- Total investments: 184
- Round size: Seed $803k–$3.3M; Angel $376k–$1.3M; Venture - Series Unknown $915k–$8.5M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Scopia Surgical — Revolutionizing the operating room with our real-time artificial intelligence image processing technology. Scopia Surgical is a co-pilot for the human body, guiding surgeons with unprecedented accuracy and confidence.
- Galaxia — GALAXIA Mission Systems designs and develops intelligent satellites and edge computation platforms for space.
- Elisa Interactive — Elisa Interactive operates an asset-light, prompt-to-environment software model designed to lower technical entry barriers in user-generated gaming ecosystems. Its core application platform, Me-Z-Scene, utilizes artificial intelligence to automatically arrange existing asset kits into complex 3D worlds based on natural language inputs. Thecompany's value proposition centers on empowering casual gamers and amateur builders to deploy custom virtual spaces without requiring coding or digital design expertise.
Innovacorp is an early-stage venture capital firm that helps knowledge-based startups commercialize their technologies in the global marketplace. It invests in early stage Nova Scotia entrepreneurs, combining venture capital with business mentoring and incubation facilities. Innovacorp was established in 1995 and based in Halifax, Canada.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Grant, Pre-Seed
- Geography: Canada, United States, Australia
Investor stats
- Total investments: 182
- Round size: Seed $50k–$3.1M; Grant $25k–$94k; Pre-Seed $19k–$1.8M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $40M in 2016
Portfolio highlights
- Bright Breaks — Bright Breaks offers a workplace wellness solution to boost employee wellness, connection, and productivity with 7-minute live micro-breaks. Bright Breaks' wellness platform is designed to provide users with maximum benefits while requiring the least amount of effort. It only takes a few minutes per day to reduce stress and improve well-being.
- Planetary — Planetary restores the chemistry of seawater so it can do what it has always done: support life and protect the planet.
- Planetary — Planetary restores the chemistry of seawater so it can do what it has always done: support life and protect the planet.
Innovate Calgary is a central innovation hub at the University of Calgary. See our programs and fundings and learn more about our innovation hubs here.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 43
- Round size: Seed $931k–$2.1M; Pre-Seed $48k–$770k
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- MACH32 — MACH32 is a medical device startup that develops innovative solutions for new and longstanding medical problems.
- Difinity Solutions — Difinity Solutions is specializing in the development of medical devices and technology solutions.
- Possibility Neurotechnologies — Connecting hearts and minds while fostering community through simple, accessible brain-controlled technology. #BCIs #assistivetech #inclusion
Sustainable, Profitable Impact Investing
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 24
- Round size: Seed $571k–$5.5M; Pre-Seed $281k–$1.5M; Series A $5M–$15M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- Modality.AI — Modality.ai is an AI-powered platform that detects health conditions using conversational AI. Through dialogue and video, Modality.AI interacts conversationally with the patient to provide health assessment anywhere, anytime. Its system analyzes multimodal data which allows continuous screening and assessing of patients’ health.
- Northernmost — Northernmost is a company that develops machines that protect and transport donated kidneys for transplantation.
- Variational AI — We are a team of AI/machine learning and business specialists using advanced generative AI for drug discovery. We collaborate closely with biopharmaceutical partners to develop new therapeutics across disease areas, aiming to positively impact lives.
iGan Partners is one of Canada's largest healthcare-focused venture capital firms, investing across North America. We provide capital and expertise to scale innovative healthcare solutions.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 50
- Round size: Seed $500k–$5.2M; Series A $3.9M–$17M; Venture - Series Unknown $10M–$14M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $250M in 2022
Portfolio highlights
- Docsi — DOCSI provides preference card optimization, surgeon engagement and supply chain cost reduction through novel digital solutions.
- Exact Imaging — Exact Imaging is the developer of the ExactVu™ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution. The system enables visualization and targeting of suspicious regions, in addition to performing systematic TRUS biopsies for prostate cancer imaging.
- Adenocyte — Adenocyte. Early detection and prevention of pancreatic cancer.
Startup TNT is a non-profit organization that emphasizes community building of investors, entrepreneurs and cheerleaders, who gather every week and build friendships before companies. Previously generated more than $3 Million capital for local startups, TNT aims to transform Alberta into Canada's be
Show more...Investment focus
- Industry: Software, Health Care, Medical Device
- Stage:Pre-Seed, Seed, Series B
- Geography: Canada, United States
Investor stats
- Total investments: 59
- Round size: Seed $56k–$2.1M; Pre-Seed $25k–$1.2M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Simuhealth — Simuhealth is a platform that helps simulation centers run more efficiently. It brings together everything you need to schedule sessions, manage equipment, track learners, and report on outcomes - all in one place. Instead of juggling spreadsheets, emails, and disconnected tools, simulation teams can use Simuhealth to coordinate day-to-dayoperations from a single, modern system.
- Northernmost — Northernmost is a company that develops machines that protect and transport donated kidneys for transplantation.
- Elle, MD Biotechnologies — Your terms. Your body. Just Livv.
We are BDC, the bank for Canadian entrepreneurs. We support small and medium-sized businesses in all industries and at every stage of growth with money and advice. We are the Business Development Bank of Canada.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Seed, Debt Financing
- Geography: Canada, United States, Nigeria
Investor stats
- Total investments: 360
- Round size: Seed $300k–$5M; Debt Financing $100k–$78M; Venture - Series Unknown $500k–$40M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- Axya — Optimize manufacturing procurement with Axya. Enhance visibility, streamline collaboration, and automate tasks. Say goodbye to spreadsheet chaos and email overload.
- Quadshift — Quadshift provides software solutions to thousands of businesses in a variety of vertical markets by acquiring and building great B2B software companies and holding them for the long term.
- TickTrade Systems — smartTrade Technologies is a leading global provider with multi-asset electronic trading platforms, helping buy-side & sell-side institutions
NorthSpring Capital Partners provides risk capital to small and medium sized companies with the goal of creating value. Investments range between $250,000 and $1 million in the form of subordinated debt and/or equity across a variety of traditional industries located in Southern Ontario. NorthSpring takes a flexible approach when reviewinginvestment opportunities and tailors its investment structure to fit the unique aspects of the business.
Show more...Investment focus
- Industry: Health Care, Medical Device, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 19
- Round size: Seed $675k–$5M; Pre-Seed $1.6M–$1.8M; Series A $5M–$11M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Mesosil — Mesosil develops responsive antimicrobial materials to prevent infection at the medical device-tissue interface, with lifetime length of effect. Our technology is ideally suited for dental restoratives and dental implant surfaces. The result is greatly improved patient outcome with no change to practitioner workflow, reducing the likelihood ofrecurrent caries and detachment of dental restorations, or peri-implant wound infection that could result in implant loss and implant revision.
- YOURIKA — AI-assisted education technology and student support
- Noa Therapeutics — Defying the convention of traditional drug development to revolutionize treatment options for complex inflammatory skin diseases.
WUTIF Capital (VCC) Inc. is a novel angel fund that co-invests with angel investors in promising new technology ventures in British Columbia. WUTIF was formed in mid-2003 and made its first investments in late 2004.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Canada
Investor stats
- Total investments: 77
- Round size: Seed $100k–$3.8M; Pre-Seed $279k–$1.5M; Venture - Series Unknown $200k–$5.5M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
- Carbonyx — Carbonyx transforms waste into carbon-negative advanced materials for industry.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is a biotechnology company pioneering the therapeutic use of RNA nanomedicine to treat disorders of the central nervous system.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!MEDTEQ+ is a non-profit organization for industrial research and innovation in medical technology. The organization accelerates the development of innovative technological solutions to improve patients’ health and quality of life by mobilizing Canadian talents. They bringing together the key players in healthcare and innovation allows them andtheir partners, to offer Canadians access to novel solutions.MEDTEQ’s mission is, through collaborative, industry-led projects, to accelerate innovation and position, on a global scale, products and services developed by the Canadian medical technologies industry.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Canada, United States
Investor stats
- Total investments: 36
- Round size: Seed $1.5M–$4M; Series A $3M–$20M
- Lead/follow: 53% lead, 47% follow
- Last fund: May invest from a new fund soon — raised $11M in 2018
Portfolio highlights
- AI4Eyes — AI4Eyes offers an end-to-end AI software & data collection platform for fast, precise, and consistent ocular diagnostics, enabling clinicians to detect and improve eye health.
- NURA Medical — Discover NurEx's medication safety software and its novel weight estimation technology, designed for healthcare professionals. Experience easy-to-use pediatric dosing, accurate weight measurement, and streamlined formulary management to enhance patient safety and reduce medication errors. Book a demo today.
- Swiftsure Innovations — Swiftsure Innovations provides registered nurses with the tools required to improve patient outcomes.It develops a medical device that enhances oral care for patients on life support with the aim of decreasing the incidence of ventilator-acquired pneumonia, length of mechanical ventilation, and length of hospital stay.Creative Destruction Labssupports the company.
MaRS Innovation (MI) is a commercialization engine that integrates, centralizes and accelerates time to market of the discovery and intellectual property assets from its 15 world-class research institutions. MI’s discovery and innovation pipeline is derived from $1 billion in annual R&D funding. Created as a not-for-profit organizationthrough the Government of Canada’s Center of Excellence for Commercialization and Research program (CECR), MI has raised $50 million from federal and provincial governments, member institutions and industry partners. MI’s vision is to transform the Toronto-based research enterprise into one of world’s most successful commercialization clusters.Through detailed, market facing due diligence, MI identifies opportunities from Canada’s largest academic cluster for further development and commercialization through project management, intellectual property management, investment and technology development. By crossing the innovation gap, MI transforms these opportunities into successful high-value licensing transactions and financeable start-up companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Pre-Seed, Grant
- Geography: Canada, United States
Investor stats
- Total investments: 87
- Round size: Seed $73k–$8M; Grant $13k–$100k; Pre-Seed $22k–$525k
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- HDAX Therapeutics — HDAX Therapeutics novel modality unlocks a never-seen-before binding mechanism to key biological molecules.
- Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
- Grey Matter Neurosciences — Empowering seniors to restore brain function through the unique power of focused ultrasound.
Working with Ontario talent to develop World Class Companies Learn More
Show more...Investment focus
- Industry: Software, Analytics, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 177
- Round size: Seed $375k–$4M; Pre-Seed $409k–$1.5M; Series A $2.3M–$14M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $8.5M in 2014
Portfolio highlights
- thri5 — Thri5 develops software that connects retail data, people, and AI agents to coordinate operational actions.
- SELL IT9 — Get top cash for your tech with SELLIT9, Canada's trusted trade-in service. Free same-day pickups, convenient drop-off locations, and pre-paid shipping labels nationwide. Fast, secure, and hassle-free!
- Daedal Systems — Daedal Systems delivers nuclear instrumentation, plasma diagnostics, and engineering services for fusion and small modular reactor projects.
The E-Fund (VANTEC Entrepreneurs Fund VCC Inc.) was established in 2011 to invest in promising new ventures in British Columbia in a wide range of industry sectors. They are focused on co-investing with other angel investors and early-stage venture capital firms in seed-stage companies with high growth opportunities.The E-Fund involvesspecific investors in the investment due diligence process depending on their industry experience and knowledge and their particular technical expertise. It is their goal to become the ‘Go-to Braintrust’ for active and in-depth angel investing.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Canada, China, United States
Investor stats
- Total investments: 62
- Round size: Seed $474k–$4.2M; Pre-Seed $279k–$1M; Venture - Series Unknown $913k–$43M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Qase — Qase helps law firms and legal referral organizations streamline referrals, automate intake and booking, and collect forwarding fees online.
- ViewsML — Explore cutting-edge AI solutions for cancer treatment, diagnosis, and research. Discover how clinical labs leverage artificial intelligence for precise cancer detection and diagnosis.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is a biotechnology company pioneering the therapeutic use of RNA nanomedicine to treat disorders of the central nervous system.
Join Angel One Investor Network: Your Path to Profitable Investments. Curated ventures, expert angel investors, and more. Take action now!
Show more...Investment focus
- Industry: Software, SaaS, Internet
- Stage:Angel, Seed, Series A
- Geography: Canada, United States, Malaysia
Investor stats
- Total investments: 74
- Round size: Seed $250k–$2.3M; Angel $68k–$2M; Series A $1.1M–$7M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Torum — Convert your crypto to Ringgit and spend it at any DuitNow QR-enabled merchant with ease.
- Coldblock — Coldblock delivers short-wave infrared sample digestion technology to prepare samples for analysis, accuracy, and safety. They offer services that include mining assays, environmental testing, food testing, metal assays, laboratory technology, and sample digestion.
- fraction/al — Fan Ownership Platform that empower fans to own a piece of their favorite sports team.
Ontario Centre of Innovation provides a preeminent research-to-commercialization vehicle in Ontario
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Pre-Seed, Grant
- Geography: Canada, United States
Investor stats
- Total investments: 53
- Round size: Seed $366k–$3.2M; Grant $7.3k–$110k; Pre-Seed $151k–$2.5M
- Lead/follow: 40% lead, 60% follow
Portfolio highlights
- Synmedix — Synmedix's mission is to provide new therapies that avoid the pitfalls of the past by avoiding resistance, addressing clinical gaps, and delivering solid economics in an equitable manner. It is a biotechnology company. For inquiries, email, telephone numbers, and physical addresses are available on their website.
- mDETECT Inc — mDETECT Inc. is a third-generation liquid biopsy company aimed at improving the clinical management of solid tumour cancers. Our blood tests provide a rapid assessment of cancer progression and response to therapy. Home https://static.wixstatic.com/media/a41d6b_4f3b85e3670a4bc2bb97fad03b256715%7Emv2.jpg mdetect
- blair health — Blair Health provides virtual menopause and midlife healthcare through assessments, treatment plans, clinician visits, and ongoing support.
Zoic Capital is the only US-based venture firm focused on early-stage healthcare innovations at the intersection of life sciences and medical technology.Promising Scientific Advancements: We look for breakthroughs with the potential for broad IP and commercial-ready maturity. We invest in roadmaps that leverage a core innovation across manyapplications and industries.Focus on Life Sciences: We see the most exciting advancements coming from life sciences labs, becoming tools that maintain and treat our health. We look at both technologies that enable development and care delivery devices.We Follow the Numbers: We follow our gut, but we also reinforce each of our decisions with numbers. We believe that merging qualitative and quantitative analysis is the best way to make successful investment decisions.Mentored Capital: We have the skills, experience and network to help, working closely with select teams to transform research into high impact, market-ready products.Milestone-Based Investing: We craft unique deal structures for each portfolio company based on mutually defined milestones. We find this approach creates ongoing momuntum and sets us all up for success.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Series B
- Geography: United States, Canada
Investor stats
- Total investments: 25
- Round size: Seed $3M–$4M; Series A $7.2M–$7.2M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely still investing — raised $380k in 2023
Portfolio highlights
- Chromatan — ChromaTan is solving a major process bottleneck in therapeutic protein production while significantly lowering the cost of goods for biotech and contract manufacturing companies. Our CCTC platform provides an inexpensive column-free, continuous, and single-use solution that will replace large scale column chromatography processes used in biologicsmanufacturing. The platform has been through extensive beta testing with over a dozen of major biotech companies and has consistently shown a 5-15X increase in throughput at an equivalent or better product quality.
- ProbiusDx — At Probius, we are redefining biochemical analysis to drive research and advance healthcare.
- Trio Labs — The speed of metal additive manufacturing, the precision of CNC machining.
The Ontario Brain Institute works to establish Ontario as a world leader in brain research, commercialization and care.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: Canada, United States, France
Investor stats
- Total investments: 57
- Round size: Seed $38k–$14M; Grant $50k–$100k
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- Better Bionics — Better Bionics is a company developing affordable, high-function upper-limb prosthetics powered by AI-driven control systems.
- Prescia Health — Prescia Health is a digital health and cognitive neuroscience company.
- PragmaClin — PragmaClin Research Inc. is aiming to help patients monitor their symptoms faster with the use of our remote patient monitoring system, PRIMS (Parkinson's Remote Interactive Monitoring System).
BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on technology-based businesses that have high growth potential and that are positioned to become dominant players in their markets. The company helps create and develop strongCanadian businesses through financing, consulting services and securitization, with a focus on small and medium-sized enterprises.BDC Venture Capital has been involved in venture capital since 1975 and has to date invested in more than 400 companies involved in the areas of Life Sciences, Telecommunications, Information Technology and Advanced Technologies.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 571
- Round size: Seed $387k–$4.5M; Series A $2.7M–$21M; Venture - Series Unknown $1.5M–$40M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — raised $500M in 2022
Portfolio highlights
- Cytochroma — Cytochroma is a clinical stage specialty pharmaceutical company that designs, develops and commercializes prescription products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism (SHPT) associated with chronic kidney disease (CKD). The Company has an advanced portfolio of new therapiesdesigned to safely and effectively treat patients with vitamin D insufficiency and SHPT associated with Stage 3, 4 or 5 CKD. In addition, Cytochroma is developing novel therapies to treat elevated blood phosphorus levels (hyperphosphatemia) in order to improve the control of SHPT in CKD patients.
- LeddarTech — The leader in environmental sensing, fusion and perception for automotive and mobility, LeddarTech delivers actionable data for autonomous driving and ADAS.
- Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.
Thin Air Labs is the leading investment firm in Canada focused on the growth asset class in innovation and technology. We currently have 24 companies in our portfolio. We believe in igniting venture growth for greater human impact.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: Canada
Investor stats
- Total investments: 34
- Round size: Seed $1M–$5.2M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely still investing — raised $20M in 2022
Portfolio highlights
- Clinify Inc — Medical records are barely digitized in Africa. The lack of digitally centralized health records has led to a large number of preventable deaths as a result of wrong and self diagnosis by patients due to poor to no medical histories, paper record mismatch, long wait times and missed revenue opportunities. There is also a shortage of healthcarepractitioners and a lack of stable healthcare infrastructure.We are building a health information management system that leverages the capabilities of Artificial intelligence. Our solution cuts wait time in half, enables users to easily access, populate, own and centralize their health records. This allows them to control and better understand their encounters, book appointments via a web portal and mobile app, have virtual consultation with healthcare professionals and providers while running it on a low cost infrastructure without affecting system performance.
- PayShepherd — PayShepherd helps manage contractor billing for industrial facilities and simplifies billing processes. Save time, money, and headaches.
- Quickly — The trusted platform to provide valuable discounts on payables, offer trade credit extensions and manage the entirety of your transaction process.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We transform the most promising oncology innovations into highly competitive opportunities that benefit patients, researchers, investors, and Ontario's economy.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical Device
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 31
- Round size: Seed $1.5M–$8M; Series A $11M–$35M
- Lead/follow: 29% lead, 71% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Esphera SynBio — Creating modified exosomes that can be designed to have targeting moieties on their surface and a variety of protein or RNA payloads in their lumen.
- Hyivy Health — Better care happens when the entire system is supported. Meet Hyivy's connected platform for pelvic care.
- Radiant Biotherapeutics — Radiant Biotherapeutics: Transformative, multi-valent, multi-specific antibody platform: Multabody
The Ontario Centres of Excellence invests in projects and people to accelerate industry R&D to impact the Ontario economy through the commercialization of leading edge research.OCE invests in- Industry-Academic collaborative research- Commercialization of academic research through licensing and spin off companies- Early stage seedfinancing of start-ups- Skills development for high quality personnelThe Ontario Centres of Excellence is a not-for-profit corporation founded in 1987. Core funding is provided by the Ontario Ministry of Research and Innovation
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Grant, Pre-Seed
- Geography: Canada, United States
Investor stats
- Total investments: 150
- Lead/follow: no public data
Portfolio highlights
- Uride — Welcome to Uride - your reliable and affordable ridesharing service with a community-focus. Enjoy the ease of quick pickups, lower fares, and a user-friendly app designed to make your travels smoother. Start riding today!
- FluidAI Medical — Real-Time Monitoring for Anastomotic Leaks with Origin, by FluidAI. Early data shows FluidAI's Origin can detect leaks an average of 1.6 days earlier.
- Novel Biotechnology — Novel Biotechnology is building high-throughput bacterial platforms for the biotech industry, with a focus on plasmid DNA manufacturing.
Boutique Venture Partners specializes in early-stage investments in healthcare and life sciences
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, France
Investor stats
- Total investments: 37
- Round size: Seed $2.5M–$5.7M; Pre-Seed $1.8M–$2.6M; Series A $4M–$31M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Handl Health — Making healthcare price transparency simple, insightful and actionable.
- Smartlens — Smartlens, Inc. is a medical technology company making non-invasive soft contact lenses as a convenient and affordable way of diurnal IOP (eye pressure) measurement. Smartlens helps with screening, diagnosis, and treatment of Glaucoma - the leading cause of irreversible blindness.
- Ventaris Surgical — Ventaris Surgical is a medical equipment company that provides surgical instruments to specialists.
Canada's leading early-stage investor community in Waterloo, funding innovative startups across tech sectors with a strong focus on impact and diversity.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Angel, Seed, Grant
- Geography: Canada, United States, China
Investor stats
- Total investments: 57
- Round size: Seed $500k–$2.4M; Angel $400k–$677k
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- MesoMat — Boost fleet safety, fuel consumption, and operating costs real-time data from your tires.
- YOURIKA — AI-assisted education technology and student support
- Motion Gestures — Motion Gestures is a Canadian machine learning startup specializing in gesture recognition software. Motion Gestures specializes in machine learning-based gesture recognition software and was founded in Waterloo, Canada in 2016. The company aims to enable the rapid development and deployment of gesture-enabled interfaces for systems, devices, andapps. Its software supports advanced 2D and 3D gestures using motion, touch, and vision sensors and can be deployed on the cloud, gateway/hub, and embedded platforms. Developers are offered free licenses to the cloud SDK and can quickly create and test any gesture using their smartphones.
Grand Challenges Canada is dedicated to supporting Bold Ideas with Big Impact® in global health. They are funded by the Government of Canada and they fund innovators in low- and middle-income countries (LMICs) and Canada. The bold ideas they support integrate science and technology, social and business innovation – they call this IntegratedInnovation®. They focus on bringing successful innovation to scale, catalyzing sustainability and impact. They have a determined focus on results, and on saving and improving lives.Grand Challenges Canada works closely with Canada’s International Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR) and Global Affairs Canada to catalyze scale, sustainability and impact. Grand Challenges Canada takes an evidence-based approach to development innovation to save and improve lives in LMICs. They are a platform for development innovation in Maternal, Newborn and Child Health (MNCH) through their Saving Lives at Birth, Saving Brains and MNCH Stars in Global Health programs. They are also focused on helping the poorest and most vulnerable populations, for example those who suffer from mental illness.Since their launch in 2010, Grand Challenges Canada has supported a pipeline of over 700 projects in more than 80 countries. Their investments are producing results: Thousands of lives have been saved and over two hundred and eighty thousand lives have been improved, thus far. By 2030, these innovations have the potential to save hundreds of thousands of lives and improve millions of lives.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Grant, Debt Financing, Seed
- Geography: Canada, United States, India
Investor stats
- Total investments: 15
- Round size: Grant $100k–$423k; Debt Financing $765k–$11M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Hewatele — Hewatele is a social enterprise that provides affordable quality medical oxygen to all needy patients together with its affiliates CPHD and Mediquip Global.
- Dawa Health — DawaMom is a standardized mobile clinic that delivers maternal and neonatal health through a digital health platform leveraging a wide network of trained 1st level clinicians and community health workers (CHWs) for emerging markets.
- Karma Healthcare — Karman Healthcare are see a world where everyone has an opportunity and means to access equitable and affordable healthcare.
The Atlantic Canada Opportunities Agency works to create opportunities for economic growth in Atlantic Canada by helping businesses become more competitive, innovative and productive, by working with diverse communities to develop and diversify local economies, and by championing the strengths of Atlantic Canada. Together, with Atlantic Canadians,we are building a stronger economy.
Show more...Investment focus
- Industry: Manufacturing, Software, Health Care
- Stage:Grant, Debt Financing, Seed
- Geography: Canada, United States, France
Investor stats
- Total investments: 242
- Round size: Seed $25k–$2M; Grant $36k–$2M; Debt Financing $141k–$1.1M
- Lead/follow: 84% lead, 16% follow
Portfolio highlights
- QRA — QRA works with global organizations to automate the quality and consistency of engineering requirements. Their software tool QVscribe enables teams to identify risk, errors, and ambiguities before they manifest into late-stage rework, cost-overruns, and recalls.
- Deep Cove Aqua Farms — Deep Cove Aqua Farms is a live lobster holding facility and seafood processing plant. The company acts as a wholesale business, seafood market, purchasing premium seafood directly from local fishermen, grading the catch by quality and size, and distributing it to domestic and international clients.
- LED Roadway Lighting — Liveable Cities produces smart LED lighting manufactured in Canada. Intelligent LED street lighting systems are being used across Canada and throughout the world. Contact us to learn more about our smart street lighting and city sensor systems, available internationally.
Sunhope Capital is a venture capital firm.
Show more...Investment focus
- Industry: Health Care, Medical Device, Health Diagnostics
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Canada, United States, Austria
Investor stats
- Total investments: 16
- Round size: Seed $100k–$2.5M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Medicus AI — Medicus AI is an innovative technology company that helps people understand their health by explaining their medical reports and health data to them in a personalized, easy-to-understand, and visual way.Through its consumer apps and enterprise software, Medicus is focused on bringing meaning to data, by helping patients and users understand theirhealth, and augmenting the roles of doctors, midwives, and other healthcare providers through innovative data visualization, patient communication, and remote monitoring tools.
- SchoolConex — Launch your online OSSD program under your own brand with a branded LMS, course shells, Ontario teacher support, and inspection-ready operations.
- Sonic Incytes — Velacur ONE is a fatty liver disease NIT quantifying real-time measurements of stiffness and attenuation in a point of care setting.
Women-powered capital building the Financial Feminist Economy.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Grant, Pre-Seed
- Geography: Canada, United States, United Kingdom
Investor stats
- Total investments: 60
- Round size: Seed $931k–$4.2M; Pre-Seed $273k–$1.6M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $30M in 2023
Portfolio highlights
- NLPatent — Accelerate productivity and uncover hidden insights with NLPatent's intuitive AI-powered patent research platform.
- Coral — Coral is a virtual care clinic that provides evidence-based, personalized support for perimenopause and menopause, weight loss and longevity.
- Axo Longevity — Axo Longevity offers membership-based biomarker testing and digital health plans for preventive wellness and longevity optimization.
Genome BC, a non-profit research organization, leads genomics innovation on Canada’s West Coast and facilitates the integration of genomics into society. Their major investors are the Province of British Columbia and the Government of Canada through Genome Canada and Western Economic Diversification Canada. This funding is complemented bypartnerships with many national and international public and private funding organizations to drive BC’s bioeconomy.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Grant
- Geography: Canada
Investor stats
- Total investments: 17
- Round size: Seed $1M–$4.7M; Venture - Series Unknown $370k–$586k
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- Verdi Expeditions — Verdi is building the world's first truly scalable platform for farm automation. We work with the world's largest food brands to grow better and more sustainable crops.
- BugSeq Bioinformatics — We're empowering microbiology labs to prevent and treat infections with nucleic acid sequencing.
- CereCura Nanotherapeutics — CereCura Nanotherapeutics is a biotechnology company pioneering the therapeutic use of RNA nanomedicine to treat disorders of the central nervous system.
Built by founders, for founders. Garage Capital helps best-in-class companies jump from garage to growth.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 145
- Round size: Seed $1.7M–$7.5M; Pre-Seed $765k–$3.6M; Series A $7.7M–$50M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — last raise in 2017
Portfolio highlights
- Astrus — Astrus fully automates analog layout using AI without disrupting your workflow.
- Orbits — Orbits is a family-focused home management platform that simplifies household tasks, schedules, and everyday organization.
- Daedal Systems — Daedal Systems delivers nuclear instrumentation, plasma diagnostics, and engineering services for fusion and small modular reactor projects.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Graphene - venture fund for innovative startups.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Series A, Seed, Venture - Series Unknown
- Geography: United States, Brazil, Saudi Arabia
Investor stats
- Total investments: 59
- Round size: Seed $1.4M–$7M; Series A $5.1M–$27M; Venture - Series Unknown $5.2M–$170M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- CUB — CUB develops a platform that automates the management of receivables and after-sales for subdivisions. It replaces manual routines to save time, and resources, and reduce bad debt.
- Decoda Health — Decoda Health is building the most powerful AI-enabled platform for medical practices.
- Smartlens — Smartlens, Inc. is a medical technology company making non-invasive soft contact lenses as a convenient and affordable way of diurnal IOP (eye pressure) measurement. Smartlens helps with screening, diagnosis, and treatment of Glaucoma - the leading cause of irreversible blindness.
Bluesky Equities is a Calgary based private investment firm.
Show more...Investment focus
- Industry: Software, Information Technology, Analytics
- Stage:Seed, Series A, Series B
- Geography: Canada, United States
Investor stats
- Total investments: 37
- Round size: Seed $500k–$3.3M; Series A $4.4M–$24M; Series B $5.4M–$43M
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- ResVR — Let buyers explore any floor plan, elevation, and finish package instantly, from anywhere. ResVR turns static renderings into an interactive, always-on sales experience.
- Wisedocs — The Wisedocs platform makes it easy to sort, understand, and organize messy, unstructured medical, legal, and insurance documents.
- Nimble Science — small intestine sampling technology - Nimble Science
Accelerate Fund supports the growth of early-stage Alberta technology companies with a multi million dollar fund that combines co-investment from angel investors.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Canada, United States
Investor stats
- Total investments: 62
- Round size: Seed $1M–$7.1M; Series A $961k–$13M; Venture - Series Unknown $360k–$1.5M
- Lead/follow: 27% lead, 73% follow
- Last fund: May invest from a new fund soon — raised $15M in 2020
Portfolio highlights
- Helcim — Helcim is the easy and affordable solution for small and medium businesses accepting payments in-person or online.
- Cellar Insights — Maximize the value of your potato crop with smart remote monitoring. Monitor storage conditions and prevent crop loss with Cellar Insights.
- Fairly Staffing — The modern dental staffing platform. Connect your clinic with vetted dental hygienists and assistants, or find flexible temp dental jobs near you with Fairly.
Whitecap Venture Partners is a Canadian-based Venture Capital fund investing in early stage technology companies. Whitecap is headquartered in Toronto and invests across Canada and the Northeastern US. Since Whitecap’s inception the early 1990s, Whitecap recognises the power of real collaboration between entrepreneurs and investors. This rapportenables them to provide significant value to companies along with strong returns across investment cycles.Whitecap specialises in Information & Communication Technologies (ICT) and Medical Technologies. Whitecap is continually searching for upcoming ventures to support as the next generation of exceptional enterprises.
Show more...Investment focus
- Industry: Software, Health Care, Enterprise Software
- Stage:Series A, Seed, Series B
- Geography: Canada, United States, Spain
Investor stats
- Total investments: 56
- Round size: Seed $1.9M–$5.4M; Series A $4.1M–$17M; Series B $8.9M–$33M
- Lead/follow: 55% lead, 45% follow
- Last fund: Likely still investing — raised $110M in 2021
Portfolio highlights
- thri5 — Thri5 develops software that connects retail data, people, and AI agents to coordinate operational actions.
- Branch Energy — A tech-powered, green energy provider focused on helping consumers reduce their energy bills and carbon footprints
- Future Fertility — Future Fertility is a fertility technology company focused on AI-enabled and non-invasive diagnostic solutions to optimize decision making throughout the IVF journey, maximizing the probability of positive outcomes in IVF workflows. The first product is an egg assessment software, which uniquely provides insights in egg quality and has thepotential to improve success rates of IVF, egg freezing and egg donation cycles.
Boreal Ventures invest in some of the deep tech companies from Centech and from the rest of the Quebec ecosystem.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, Spain
Investor stats
- Total investments: 24
- Round size: Seed $761k–$4M; Pre-Seed $481k–$6M; Series A $10M–$12M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely actively investing — fresh fund, raised $31M in 2026
Portfolio highlights
- EAIGLE — Save $726K a year per facility with autonomous gate and yard automation. AI-powered check-in in 30 seconds, live at Fortune 500 yards across North America.
- Paraito — Paraito is an AI-powered platform that automates title examinations at the Land Registry for notaries in Quebec, Canada. By leveraging artificial intelligence, Paraito dramatically reduces the time and cost involved in real estate transactions, allowing notaries to focus on higher-value work while improving accuracy and compliance.
- My FLiiP — FLiiP is the gym management software built for commercial gyms in Canada and beyond. It unifies CRM, member management, billing, a branded app, and AI on one platform, the smart way to grow your gym, not just manage it.
Leva Capital invests in privately owned businesses within the healthcare sector in Canada, from startups to medium sized companies looking to partner and leverage our full toolbox, not only the funds.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States
Investor stats
- Total investments: 12
- Round size: Seed $1.9M–$3.6M; Pre-Seed $893k–$5M; Series A $12M–$15M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Eli — At-home hormone testing from Eli Health: track cortisol, progesterone, and testosterone with saliva tests that deliver lab-grade results in 20 minutes.
- Northernmost — Northernmost is a company that develops machines that protect and transport donated kidneys for transplantation.
- FluidAI Medical — Real-Time Monitoring for Anastomotic Leaks with Origin, by FluidAI. Early data shows FluidAI's Origin can detect leaks an average of 1.6 days earlier.
Desjardins Capital is a banking firm that offers practical tools, expert advice, and testimonial services. By making investments in the expansion and long-term success of regional companies, Desjardins Capital supports the long-term prosperity of individuals and their communities.
Show more...Investment focus
- Industry: Manufacturing, Software, Information Technology
- Stage:Seed, Series A, Private Equity
- Geography: Canada
Investor stats
- Total investments: 42
- Round size: Seed $1M–$5.1M; Series A $9.3M–$30M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- AON3D — AON3D is a manufacturer of high-temperature industrial 3D printers.The AON-M2, its flagship 3D printer, is a direct response to demands for hotter print conditions and the careful thermal control needed for producing strong and dimensionally stable parts from advanced materials. It offers an open filament platform that empowers users to choosethe right materials for their project and slash costs by avoiding expensive proprietary materials and license fees.Founders Andrew Walker, Randeep Singh, and Kevin Han established the company in 2015 in Montreal, Quebec.
- Relocalize — Relocalize is a food tech platform that produces, processes, and packages food locally using automated micro-factories.
- Boucher Lortie — Boucher Lortie specializes in plumbing, electrical services, heating, natural gas, air conditioning and refrigeration.
Avego is a multi-strategy investment firm specializing in healthcare. Our mission is to unite our industry expertise and capital with entrepreneurs and management teams to deliver successful results and improve the lives of patients.
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Medical
- Stage:Series A, Series C
- Geography: United States, Canada, United Kingdom
Investor stats
- Total investments: 8
- Round size: Series A $40M–$197M; Series C $120M–$120M
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- CellCentric — CellCentric’s primary programme targets a deubiquitinase (DUB) enzyme which is strongly associated with prostate cancer, a leading cause of mortality among men. The target modulates the androgen receptor pathway and can potentially combat the multiple resistance mechanisms seen with recently approved prostate cancer drugs such Xtandi and Zytiga.The programme also has potential clinical utility in non-small cell lung, breast and colon cancer.
- PBS Biotech — Progressive Biomanufacturing Systems (PBS) Biotech is the leading provider of innovative, single-use bioreactors for cell-based therapies.
- Alveus Therapeutics — At Alveus Therapeutics, we are building a differentiated therapeutic portfolio that delivers sustainable weight loss with superior tolerability.
Invest in High-Growth Startups
Show more...Investment focus
- Industry: Artificial Intelligence, Software, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 69
- Round size: Seed $1.4M–$6.1M; Pre-Seed $500k–$3.9M; Series A $6.4M–$19M
- Lead/follow: 9% lead, 91% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- GoCab — GoCab is fintech solution providing Drive-to-own option for vehicle purchase in Emerging markets, helping to bridge the gap between mobility entrepreneurs and financial services.
- Tewke — Tewke is a London based company that was founded in 2020 developing technology to deliver energy savings through AI enabled home automation. Tewke's mission is to reduce energy consumption in homes whilst elevating everyone's living experience.Tewke's first product, Tap, is an intelligent light switch that can be installed into anyhome without rewiring. This acts as the backbone of Tewke's energy control and home automation platform, and has already won international awards, such as the Red Dot Design Award.
- Claybird — Claybird offers an AI video ad creation agent that plans, generates, edits, and publishes ad videos from concept to release.
K2X Technology & Life Science, Inc. Creating an ETF-like vehicle of diversified and thoroughly vetted startups K2X is a Silicon Valley-based FinTech offering global investors a novel, safer, higher-return, non-correlated, diversified, and liquid (assuming NASDAQ IPO completed) way to invest in the best angel-stage startups. Built and managed by experienced angel investors for the benefit
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A
- Geography: United States, Canada
Investor stats
- Total investments: 10
- Round size: Seed $1.4M–$6.3M; Series A $6M–$15M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Spintly — Spintly is a wireless cloud-based access control platform which enables users to access doors using their smartphones and eliminates more than 95% of access control cabling in buildings. Current Access control systems need extensive wiring and are bulky, occupying a ton of space in server rooms. Current access and identity management systems arenot smartphone friendly and getting data to the cloud from such systems is not trivial. Spintly cloud based smart access control system uses a wireless BLE-mesh network of access control readers to eliminate the back-end access control wiring in a building and empowers users by letting them use their smartphone as an access control device. Spintly access control system is connected to the cloud 24x7 through a wireless gateway and allows real-time monitoring of access data. Spintly offers access management solutions to Enterprises, Co-working spaces, Co-living spaces, Hospitality clients and residential communities.
- Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
- FluidAI Medical — Real-Time Monitoring for Anastomotic Leaks with Origin, by FluidAI. Early data shows FluidAI's Origin can detect leaks an average of 1.6 days earlier.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Fonds de solidarité FTQ is a private equity and venture capital firm specializing in investments in start-ups, early venture, mergers, business acquisitions, management buyouts, market development project or a buyout, financing for new programs, organic growth and cash flow, growth and expansion financings, development capital, business succession,financial restructuring, business transition financing, family and non-family buyout, consolidations, turnaround, and leveraged management buyouts. It also invests in new markets, product and business line developments, market diversification, interim financings, new product marketing, additional working capital, purchase of tangible and intangible assets, equipment modernization, equipment purchases or upgrades, and integrator projects. The firm has regional funds that do not invest in retail, real estate, farming, biotechnology, and financial services. Fonds de solidarité FTQ invests in small and medium-sized businesses. It typically invests in export projects, forest products, productivity improvement, natural resources, aerospace, agri-food, wood, pulp and paper, chemicals, construction and construction materials, printing, transportation equipment and automobiles, transportation services, furniture and fixtures, combinatorial chemistry and other lead generating technologies, mining and exploration, social economy, textiles, plastics, life sciences, business services, telecommunications, distribution and consumer goods, environment, equipment and machinery, financial services, information and communication technology, metal products, recreational tourism, and culture sectors. Within the culture sector, Fonds de solidarité FTQ seeks to invest in pre-production and creative projects, production projects, infrastructures and services, post-production projects, distribution, and broadcasting and multiplatform broadcasting. Within the environment sector, it invests in waste management and energy conversion for residual waste; air treatment and reduction of greenhouse gas emissions; processes to reduce industrial energy and water consumption; water treatment; and soil rehabilitation and decontamination (metals and organic compounds). Within the life sciences sector, Fonds de solidarité FTQ focuses on services for the biopharmaceutical industry; nutraceuticals and cosmeceuticals; diagnostics and medical supplies and equipment; biopharmaceuticals and generic drugs; biotechnology, and animal health. Within the tourism sector, it focuses on urban tourism, nature tourism, resort type tourism, and local tourism for Quebecers, and in the textiles sector it invests in companies engaged in development and production of specialty textiles as well as development of industrial applications for the construction, transportation, health and safety, and work apparel industries. Fonds de solidarité FTQ prefers to invest in Quebec and in companies impacting the Québec economy. It focuses on investing in the following regions- Abitibi –Témiscamingue, Bas Saint Laurent, Chaudière-Appalaches, Côte-Nord, Estrie, Gaspésie Îles-de-la-Madeleine, Lanaudière, Laurentides, Laval, Mauricie - Centre-du-Québec, Montérégie, Nord-du-Québec, Outaouais, and Saguenay-Lac-St-Jean. Fonds de solidarité FTQ seeks to invest in projects of $3 million or more and also provides loans of up to $ 2 million. It invests in companies in business succession sector having minimum capitalization of $500,000 and EBITDA of over $35.5 million in case of majority interest; equipment and machinery sector with average investment in excess of $3 million; environment sector with funding needs of more than $500000; financial services sector having net assets between $20 million and $50 million in equity; metal products sector having annual sales of over $5 million and financing needs of at least $2 million; and printing sector having investment needs of over $1 million. In the information technology sector, Fonds de solidarité FTQ seeks to invest $2 million as initial investments while total investments can be more than $10 million. It invests in the form of equity financing (common or preferred shares) and unsecured debt requiring no collateral (debenture). Fonds de solidarité FTQ can take both a minority interest including an equity stake of up to 49 percent as well a majority interest in its portfolio companies in case of business succession financing. It seeks a minority stake for the portfolio companies in the equipment and machinery sector. It typically holds its investments for a period of five to ten years in case of equity financing and for more than ten years in case of business succession financing. Fonds de solidarité FTQ began operation on June 23, 1983. It has its headquarters in Montreal in Canada with additional offices in the same city and Quebec in the same country.
Show more...Investment focus
- Industry: Manufacturing, Biotechnology, Software
- Stage:Series A, Series B
- Geography: Canada, United States, Israel
Investor stats
- Total investments: 228
- Round size: Series A $6M–$50M; Series B $7.5M–$75M
- Lead/follow: 45% lead, 55% follow
- Last fund: May invest from a new fund soon — last raise in 2016
Portfolio highlights
- AV&R — AV&R designs user-centric, reliable robotic systems for aerospace & medical manufacturers, automating surface finishing & inspection.
- Namakor Holdings — We combine strategic investment and in-house operational expertise to untap the true potential of your industrial manufacturing businessNamakor Holdings is a private equity firm investing in mid-market manufacturing companies, driving growth, innovation, and global expansion.
- PG Hardwood Flooring — PG Hardwood is a company which provides Prefinished hardwood, Varnished hardwood, Gymnasium wood & Solid hardwood flooring.
Nimbus Synergies leads early-stage financings in innovative and complementary digital health companies in British Columbia. By bringing these companies together to share resources, industry specific knowledge, and relationships, Nimbus is accelerating their growth and increasing their likelihood of success. Nimbus is significantly impacting theburgeoning yet underserved digital health sector through its leadership as investor, partner, and mentor. It is one of the most exciting additions to the province’s technology industry and the newest member of Discovery Parks’ group of companies. By investing Discovery Parks’ assets in startups focused on the intersection between life sciences and technology, Nimbus aims to improve health through BC-led innovation.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Seed, Series A, Non-Equity Assistance
- Geography: Canada, United States
Investor stats
- Total investments: 19
- Round size: Seed $750k–$5.5M; Series A $5.9M–$7.3M
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- A&K Robotics — A&K Robotics | Autonomous Vehicle Systems
- EmergConnect — Home page - Localized information, services, and support for Canadian visitors.
- Variational AI — We are a team of AI/machine learning and business specialists using advanced generative AI for drug discovery. We collaborate closely with biopharmaceutical partners to develop new therapeutics across disease areas, aiming to positively impact lives.
Invest in transformational technologies that can achieve large scale solutions globally.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Education
- Stage:Seed, Series A, Pre-Seed
- Geography: Canada, United States, India
Investor stats
- Total investments: 45
- Round size: Seed $1.2M–$5M; Pre-Seed $1.2M–$2.5M; Series A $7.6M–$28M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- CURA — CURA removes cement's process emissions upstream with electrochemical technology. Deep decarbonization without replacing feedstocks, plants, or standards.
- Fex Energy — FeX Energy is a pre-commercial startup focused on developing renewable energy storage solutions.
- ThinkLabs AI — Physics-informed AI agents delivering continuous automation for grid planning and operations.
Zcube is the Research Venture of the Zambon Group. It was established in 2003 to explore innovation and research in the Life Science field on a global level. Zcube has three work streams: Zcare, Open Accelerator, investments in national and international funds. It supports the development and acceleration of innovative startups
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Pre-Seed, Series B
- Geography: Italy, Canada, Lithuania
Investor stats
- Total investments: 5
- Round size: Seed $56k–$1.5M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- Vilimed — Vilimed specialises in the development of medical devices like Vilim ball which is a therapeutic device developed for hand tremor reduction.
- PharmEste — PharmEste s.r.l., a biopharmaceutical company, engages in the discovery and development of transient receptor potential (TRP) channel therapeutics for the treatment of neuropathic pain, overactive bladder, and other TRP-mediated diseases. It develops PHE377, a TRPV1 antagonist for the treatment of neuropathic pain.
- Hyivy Health — Better care happens when the entire system is supported. Meet Hyivy's connected platform for pelvic care.
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: United States, Switzerland, Canada
Investor stats
- Total investments: 85
- Round size: Seed $1M–$18M; Series A $1M–$20M; Series B $7M–$45M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- Adient Medical — Medical Devices that Automatically Vanish - Adient Medical is leading the development of an absorbable vascular filter for the prevention of pulmonary embolism.
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
- Viridian Therapeutics (Formerly MiRagen Therapeutics) — Committed to developing potential best-in-class medicines for people affected by Thyroid Eye Disease and other autoimmune and rare diseases.
New emerging manager for deep technology and digital health
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Canada, United States, Denmark
Investor stats
- Total investments: 11
- Round size: Seed $900k–$5M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Modl.ai — modl.ai uses AI agents and analysts to automate game testing and QA. Find bugs, glitches, and performance issues faster. No SDKs or code needed to get started.
- Oncoustics AI — Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. Unlike other players in the space, Oncoustics does not do image recognition. Instead, Oncoustics applies AI to raw ultrasound signals from readily available handheldultrasound devices to rapidly differentiate healthy versus diseased tissues. There's a wealth of information in these raw signals and this approach reveals novel biomarkers that can be aligned with existing standards and categorization systems. Initially targeting liver disease, a $30B global diagnostic market, Oncoustics has filed a Breakthrough Device Designation Request with the FDA for the OnX that detects liver fibrosis and the 510K is underway. Several follow-on liver products are in development. Oncoustics also has clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.
- Prescryptive Health — Prescryptive Health is a digital health company focused on improving the prescription drug market
Desjardins-Innovatech is a Canadian venture capital company that funds innovative businesses in diverse sectors across Quebec.
Show more...Investment focus
- Industry: Health Care, Software, Manufacturing
- Stage:Seed, Venture - Series Unknown, Series B
- Geography: Canada, Spain
Investor stats
- Total investments: 26
- Round size: Seed $500k–$2.7M; Series B $4.6M–$29M; Venture - Series Unknown $365k–$10M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Imagia — At Imagia Canexia Health, we make high-quality cancer genomic information accessible and affordable with our clinically-validated assays, informatics, and support.
- LeddarTech — The leader in environmental sensing, fusion and perception for automotive and mobility, LeddarTech delivers actionable data for autonomous driving and ADAS.
- Airex Energy — Industrial biomass conversion solutions for biocoal, biochar, and biocarbon using advanced torrefaction and carbonization technologies.
Real Ventures is an early-stage venture firm focused on serving daring entrepreneurs with the ambition to create successful, global companies. Since 2007, Real Ventures has dedicated itself to building the Canadian startup ecosystem on the belief that people, not money, build game-changing companies. Real Ventures provides stage-specific guidance,mentorship, and access to networks and resources to fast-track founders’ personal and company growth. Real Ventures manages $325 million across five funds and its active portfolio of 100+ companies is currently valued at $10 billion. www.realventures.com
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Canada, United States, Australia
Investor stats
- Total investments: 302
- Round size: Seed $592k–$5M; Series A $3.7M–$24M; Series B $2.9M–$47M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — raised $140M in 2017
Portfolio highlights
- Axya — Optimize manufacturing procurement with Axya. Enhance visibility, streamline collaboration, and automate tasks. Say goodbye to spreadsheet chaos and email overload.
- DropGenie — DropGenie is building connected hardware to automate gene editing. They are accelerating the pace of discovery through the generation of standardized and compatible scientific information.
- Nord Quantique — Nord Quantique creates quantum processors based on second-generation technology.
Genesys Capital is one of Canada's leading venture capital firms, investing in early-stage healthcare and biotechnology companies to drive innovation and improve lives.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Canada, United States
Investor stats
- Total investments: 35
- Round size: Series A $1.8M–$21M; Series B $10M–$105M
- Lead/follow: 17% lead, 83% follow
- Last fund: May invest from a new fund soon — raised $125M in 2016
Portfolio highlights
- Flosonics — Flosonics Medical is improving patient care through technology-enabled solutions and services that clinicians, and patients, love.
- Enspire DBS Therapy — Enspire DBS Therapy supports stroke recovery patients using deep brain stimulation with physical rehabilitation to restore motor function. Enspire DBS offers a robust method to mediate the effects of stimulation and stroke rehabilitation.
- Feldan Therapeutics — Feldan Therapeutics has developed a patented peptide-based technology platform, the Feldan Shuttle, which enables fast and safe intracellular delivery. The company's mission is to develop leading-edge therapeutic applications based on its proprietary platform, as demonstrated by its current pipeline of clinical programs taking advantage of theunique characteristics of the Shuttle.
Equation Angels is the second-largest angel investor network in Canada. It Combining the vast expertise and resources of three angel groups from Southern Ontario, It accelerate the innovation ecosystem for investors and entrepreneurs.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Pre-Seed
- Geography: Canada
Investor stats
- Total investments: 3
- Round size: Seed $675k–$1.5M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Mesosil — Mesosil develops responsive antimicrobial materials to prevent infection at the medical device-tissue interface, with lifetime length of effect. Our technology is ideally suited for dental restoratives and dental implant surfaces. The result is greatly improved patient outcome with no change to practitioner workflow, reducing the likelihood ofrecurrent caries and detachment of dental restorations, or peri-implant wound infection that could result in implant loss and implant revision.
- Hyivy Health — Better care happens when the entire system is supported. Meet Hyivy's connected platform for pelvic care.
Medical Device VC funding in Canada at a glance
Stats across 725 deals from 595 investors.
Access all 595 VC funds in Canada Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in Canada investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 595 VC funds investing in Canada Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!